Evidence map›Paper›PMID 29059593›Full record

ArticleNeurobiology of aging2018

Splenectomy protects aged mice from injury after experimental stroke.

Anjali Chauhan, Abdullah Al Mamun, Gabriel Spiegel, Nia Harris, Liang Zhu, Louise D McCullough

Open access · greenAbstract read
In one paragraph

Article in Neurobiology of aging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it, 83 citations in OpenAlex.

  1. Pooled it
  2. CIITA/PRMT5 promote CD4BMC medicine · 2026
    Article
  3. Article
  4. Article
  5. CD8Cellular & molecular immunology · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson's Disease.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2023
    Article
  14. Article
  15. Article
  16. Review
  17. The age-dependent immune response to ischemic stroke.Current opinion in neurobiology · 2023
    Review
  18. Article
  19. CD11bJournal of immunology (Baltimore, Md. : 1950) · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Anjali ChauhanDepartment of Neurology, the University of Texas McGovern Medical School at Houston, TX, USA.
Abdullah Al MamunDepartment of Neurology, the University of Texas McGovern Medical School at Houston, TX, USA.
Gabriel SpiegelDepartment of Neurology, the University of Texas McGovern Medical School at Houston, TX, USA.
Nia HarrisUniversity of Connecticut Health Science Center, Farmington, Connecticut, USA.
Liang ZhuBiostatistics & Epidemiology Research Design Core, Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA.
Louise D McCulloughDepartment of Neurology, the University of Texas McGovern Medical School at Houston, TX, USA; Memorial Hermann Hospital-Texas Medical Center, Houston, TX, USA. Electronic address: Louise.D.McCullough@uth.tmc.edu.
The University of Texas Health Science Center at Houston · USMemorial Hermann · USUConn Health · US

Funding

Center for Clinical and Translational Sciences (CCTS)UL1TR000371 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2012 to 2016
$13.4M
Reversing Age Related InflammationR01NS094543 · NINDS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCCULLOUGH, LOUISE D. · 2016 to 2020
$2.8M
The Neuroprotective Potential of TGF-beta Activated Kinase Inhibition in Acute StR21NS088969 · NINDS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCCULLOUGH, LOUISE D. · 2014 to 2015
$438k
NCATS NIH HHS UL1 TR000371NINDS NIH HHS R01 NS094543NINDS NIH HHS R21 NS088969
6 · The paper itself

Abstract

Elderly stroke patients and aged animals subjected to experimental stroke have significantly worse functional recovery and higher mortality compared to younger subjects. Activation of the peripheral immune system is known to influence stroke outcome. Prior studies have shown that splenectomy reduces ischemic brain injury in young mice. As immune function changes with aging, it is unclear whether splenectomy will confer similar benefits in aged animals. We investigated the contribution of spleen to brain injury after cerebral ischemia in aged male mice. Splenic architecture and immune cell composition were altered in aged mice. Splenectomy 2 weeks before stroke resulted in improved neurobehavioral and infarct outcomes in aged male mice. In addition, there was a reduction in peripheral immune cell infiltration into the brain and decreased levels of peripheral inflammatory cytokines after stroke in aged splenectomized mice. Splenectomy immediately after reperfusion also improved behavioral and infarct outcomes. This study suggests that inhibition of the splenic immune response is a translationally relevant target to pursue for stroke treatment in aged individuals.

Indexed as

SplenectomyAgingAnimalsBrainBrain IschemiaCytokinesInflammation MediatorsMaleMice, Inbred C57BLSpleenCytokinesInflammation MediatorsAgeImmune responseMiddle cerebral artery occlusion modelSplenectomyStroke

Identifiers

PMID29059593
PMCPMC5947993
OpenAlexW2759715932

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.